Summary

Introduced with the Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017, the bill amends the

to: enable regulations to be made prescribing an annual charge for a conformity assessment body determination payable by the Australian corporation that is the subject of the determination; provide that the obligation for a conformity assessment body to pay an annual charge continues during a period in which the conformity assessment body determination is suspended; and ensure that the annual charges prescribed for provisionally registered goods also apply to provisionally registered goods entered in the Australian Register of Therapeutic Goods.